Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Change in Accured Expenses (2021 - 2025)

Medicinova (MNOV) has disclosed Change in Accured Expenses for 8 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses changed N/A to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $428237.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $459871.0 for FY2025, 247.23% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $1.1 million at Medicinova, up from -$812979.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $1.1 million in Q4 2025, with the low at -$1.4 million in Q4 2021.
  • Average Change in Accured Expenses over 5 years is -$89217.3, with a median of $15439.5 recorded in 2023.
  • The sharpest move saw Change in Accured Expenses plummeted 512.43% in 2023, then surged 500.17% in 2024.
  • Over 5 years, Change in Accured Expenses stood at -$1.4 million in 2021, then skyrocketed by 108.21% to $111353.0 in 2022, then skyrocketed by 328.29% to $476913.0 in 2023, then tumbled by 75.84% to $115246.0 in 2024, then skyrocketed by 876.57% to $1.1 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $1.1 million, -$812979.0, and $115246.0 for Q4 2025, Q1 2025, and Q3 2024 respectively.